The FDA announced on June 27, 2019, that Medtronic MiniMed is recalling the Paradigm insulin pump, model MMT-723, due to cybersecurity vulnerabilities. An unauthorized person could potentially connect wirelessly to a nearby pump to change settings and control insulin delivery.
How to tell if you have it
- Brand: Medtronic MiniMed
- Product: Paradigm Insulin pump
- Model number: MMT-723
- Software versions: 2.4A or lower
- Units affected: 72,850
The hazard
The recall addresses potential cybersecurity vulnerabilities in insulin pumps designed to communicate using a wireless radio frequency (RF). An unauthorized person could potentially connect wirelessly to a nearby insulin pump to change settings and control insulin delivery.
Context
GovInfoNow's records show Medtronic MiniMed has had five other recalls since March 15, 2021. Other recent recalls of similar products include the Medtronic Guardian App Recall regarding data uploading risks (Nov. 21, 2022), the Medtronic MiniMed 600 Series Insulin Pumps recall for cybersecurity vulnerability risk (Sept. 20, 2022), and the Medtronic MiniMed 740G Insulin Pump recall for battery cap deterioration risk (May 23, 2022). Additional similar product recalls include the Medtronic MiniMed 670G Insulin Pump recall for risk of incorrect insulin delivery (July 13, 2026), the Medtronic Paradigm Insulin Pumps recall for risk of severe hypoglycemia or hyperglycemia (Feb. 13, 2026), and the Medtronic MiniMed 640G Insulin Pump recall for risk of incorrect insulin delivery (July 13, 2026).